Clean Yield Group Novo Nordisk A S Transaction History

Clean Yield Group

  • $296 Million
  • Q3 2024

A detailed history of Clean Yield Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Clean Yield Group holds 34,386 shares of NVO stock, worth $3.56 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
34,386
Previous 35,170 2.23%
Holding current value
$3.56 Million
Previous $5.02 Million 18.45%
% of portfolio
1.38%
Previous 1.98%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
$119.07 - $145.42 $93,350 - $114,009
-784 Reduced 2.23%
34,386 $4.09 Million
Q2 2024

Jul 10, 2024
SELL
$122.71 - $146.91 $109,457 - $131,043
-892 Reduced 2.47%
35,170 $5.02 Million
Q1 2024

May 29, 2024
SELL
$102.11 - $135.92 $393,634 - $523,971
-3,855 Reduced 9.66%
36,062 $4.63 Million
Q4 2023

Jan 24, 2024
SELL
$87.78 - $105.45 $74,174 - $89,105
-845 Reduced 2.07%
39,917 $4.13 Million
Q3 2023

Oct 12, 2023
BUY
$90.94 - $199.54 $1.96 Million - $4.31 Million
21,581 Added 112.51%
40,762 $3.71 Million
Q2 2023

Jul 26, 2023
SELL
$155.98 - $172.65 $125,563 - $138,983
-805 Reduced 4.03%
19,181 $3.1 Million
Q1 2023

Apr 26, 2023
SELL
$132.34 - $159.14 $183,290 - $220,408
-1,385 Reduced 6.48%
19,986 $3.18 Million
Q4 2022

Jan 31, 2023
SELL
$102.55 - $135.33 $40,507 - $53,455
-395 Reduced 1.81%
21,371 $2.89 Million
Q3 2022

Oct 31, 2022
SELL
$95.28 - $116.93 $9,528 - $11,693
-100 Reduced 0.46%
21,766 $2.17 Million
Q2 2022

Jul 18, 2022
SELL
$103.24 - $121.81 $81,559 - $96,229
-790 Reduced 3.49%
21,866 $2.44 Million
Q1 2022

Apr 25, 2022
SELL
$93.1 - $112.54 $466,151 - $563,487
-5,007 Reduced 18.1%
22,656 $2.52 Million
Q4 2021

Jan 24, 2022
SELL
$95.88 - $117.08 $58,870 - $71,887
-614 Reduced 2.17%
27,663 $3.1 Million
Q3 2021

Oct 27, 2021
SELL
$84.42 - $106.62 $35,456 - $44,780
-420 Reduced 1.46%
28,277 $2.72 Million
Q2 2021

Jul 26, 2021
SELL
$67.66 - $84.76 $218,880 - $274,198
-3,235 Reduced 10.13%
28,697 $2.4 Million
Q1 2021

Apr 26, 2021
SELL
$67.06 - $75.82 $136,131 - $153,914
-2,030 Reduced 5.98%
31,932 $2.15 Million
Q4 2020

Jan 26, 2021
SELL
$63.89 - $73.8 $78,584 - $90,774
-1,230 Reduced 3.5%
33,962 $2.37 Million
Q3 2020

Oct 16, 2020
SELL
$63.69 - $70.22 $56,238 - $62,004
-883 Reduced 2.45%
35,192 $2.44 Million
Q2 2020

Jul 22, 2020
SELL
$58.54 - $67.94 $810,076 - $940,153
-13,838 Reduced 27.72%
36,075 $2.36 Million
Q1 2020

Apr 20, 2020
SELL
$49.46 - $64.78 $433,813 - $568,185
-8,771 Reduced 14.95%
49,913 $3.01 Million
Q4 2019

Jan 17, 2020
SELL
$49.86 - $58.26 $62,823 - $73,407
-1,260 Reduced 2.1%
58,684 $3.4 Million
Q3 2019

Oct 23, 2019
SELL
$47.54 - $53.43 $62,039 - $69,726
-1,305 Reduced 2.13%
59,944 $3.1 Million
Q2 2019

Jul 22, 2019
SELL
$46.79 - $52.47 $131,339 - $147,283
-2,807 Reduced 4.38%
61,249 $3.13 Million
Q1 2019

Apr 24, 2019
SELL
$46.36 - $52.63 $14,835 - $16,841
-320 Reduced 0.5%
64,056 $3.35 Million
Q4 2018

Jan 23, 2019
SELL
$41.54 - $47.25 $77,305 - $87,932
-1,861 Reduced 2.81%
64,376 $2.97 Million
Q3 2018

Oct 22, 2018
SELL
$46.76 - $51.24 $7,995 - $8,762
-171 Reduced 0.26%
66,237 $3.12 Million
Q2 2018

Jul 24, 2018
SELL
$44.29 - $50.42 $103,195 - $117,478
-2,330 Reduced 3.39%
66,408 $3.06 Million
Q1 2018

Apr 23, 2018
SELL
$48.49 - $58.14 $433,258 - $519,480
-8,935 Reduced 11.5%
68,738 $3.39 Million
Q4 2017

Jan 16, 2018
SELL
$47.53 - $53.73 $43,727 - $49,431
-920 Reduced 1.17%
77,673 $4.17 Million
Q3 2017

Oct 11, 2017
BUY
$41.15 - $49.22 $3.23 Million - $3.87 Million
78,593
78,593 $3.78 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email